MedPage Today November 15, 2024
Greg Laub

— Long-lived plasma cell compartment in the bone marrow may hold the answer, says researcher

The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning protection compared with vaccines for influenza or tetanus, according to a recent study published in Nature Medicine.

In this exclusive MedPage Today video, study author Frances Eun-Hyung Lee, MD, of Emory University School of Medicine in Atlanta, discusses the findings and the implications for future research.

Following is a transcript of her remarks:

The COVID mRNA vaccines were introduced in 2021, and it’s really made a game changer for us to get out of the pandemic. But the one question is how long did those...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Journalists Address HHS Under Trump, Rural PFAS Contamination, and Bird Flu
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
It's sick season. Here's how to protect yourself from norovirus, COVID-19, flu and RSV
China marks muted 5th anniversary of first COVID death
HHS Unveils AI Strategic Plan for Healthcare, Human Services and Public Health

Share This Article